Press Release
July 8, 2021

ADVITOS Raises €20 Million in Series F Financing Round

The Frankfurt Private Equity team advised CIC Capital Deutschland GmbH and Crédit Mutuel Innovation in their role as lead investors in the €20 million Series F Financing Round of ADVITOS GmbH. In addition, as part of the round, ADVITOS received funding from the European Union's European Innovation Council fund as part of the EIC Accelerator Pilot blended finance program, which offers tailor-made support for high-growth European technology scale-ups. 

ADVITOS GmbH develops the CE-certified and globally patented ADVOS therapy (ADVanced Organ Support) — the first therapy for multi-organ support integrated in a single device. The ADVOS process improves the survival rate of patients by simultaneously supporting the three main detoxification organs of the human body: liver, lungs, and kidneys.

The Goodwin team was led by Gregor Klenk.

For more details read the press release.